≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Myeloproliferative diseases

DOID Endpoint Browser

MYELOPROF

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D75.2

1 out of 7 registries used, show all original rules.

907

4. Check minimum number of events

None

907

5. Include endpoints

3178

6. Filter based on genotype QC (FinnGen only)

3178

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 3178 1659 1519
Unadjusted period prevalence (%) 0.62 0.57 0.67
Median age at first event (years) 63.29 61.79 64.93

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2604
Matched controls
26041
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D47.3
ICD-10 Finland
Essential (haemorrhagic) thrombocythaemia
+∞
323.0
1154
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
122.4
323.0
1779
450
D47.1
ICD-10 Finland
Chronic myeloproliferative disease
+∞
323.0
397
*
9962/3-C42.1
ICD-O-3
Essential thrombocythemia of bone marrow
+∞
323.0
361
*
C92.1
ICD-10 Finland
Chronic myeloid leukaemia [CML], BCR/ABL-positive
+∞
323.0
305
*
D75.2
ICD-10 Finland
Essential thrombocytosis
564.7
323.0
612
14
D45
ICD-10 Finland
Polycythaemia vera
4145.4
323.0
1092
5
L01XX05
ATC
hydroxycarbamide; oral
2279.4
323.0
1392
13
9950/3-C42.1
ICD-O-3
Polycythemia vera of bone marrow
+∞
323.0
310
*
XW000
NOMESCO Finland
Bone marrow biopsy
28.0
323.0
880
466
TPH00
NOMESCO Finland
Phlebotomy
419.5
323.0
365
10
SPAT1074
SPAT
Venesection
164.4
255.1
266
18
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
34.8
228.5
300
97
L03AB05
ATC
interferon alfa-2b; parenteral
136.3
200.6
213
17
L01XX35
ATC
anagrelide; oral
1941.7
199.5
191
*
D75.9
ICD-10 Finland
Disease of blood and blood-forming organs, unspecified
68.4
185.8
214
34
9961/3-C42.1
ICD-O-3
Primary myelofibrosis of bone marrow
947.4
182.6
177
*
189
Kela drug reimbursment
Imatinib
214.6
175.4
180
9
L01XE01
ATC
[U] imatinib; oral
184.2
150.4
156
9
M04AA01
ATC
allopurinol; systemic
3.8
139.6
708
2326
9960/3-C42.1
ICD-O-3
Myeloproliferative neoplasm, NOS, of bone marrow
+∞
136.7
130
*
9863/3-C42.1
ICD-O-3
Chronic myeloid leukemia, NOS, of bone marrow
+∞
131.4
125
*
B99
ICPC
Blood/lymph/spleen disease other
98.5
119.2
131
14
L03AB04
ATC
interferon alfa-2a; parenteral
162.6
118.3
124
8
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.5
107.7
591
2014
174
Kela drug reimbursment
Ruxolitinib
+∞
101.7
97
*
L01EA01
ATC
imatinib; oral (bcr-abl tyrosine kinase inhibitors)
316.7
90.4
91
*
374
Kela drug reimbursment
Ruxolitinib
+∞
88.0
84
*
316
Kela drug reimbursment
Imatinib
279.5
80.0
81
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.7
78.7
381
1149
D75.1
ICD-10 Finland
Secondary polycythaemia
32.4
77.7
103
33
212
Kela drug reimbursment
Gout
8.3
76.8
177
226
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
25.0
76.0
108
45
L01XE18
ATC
[U] ruxolitinib; oral
+∞
74.3
71
*
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
15.3
69.0
116
79
L01EJ01
ATC
ruxolitinib; oral
+∞
68.0
65
*
152
Kela drug reimbursment
Nilotinib
+∞
63.8
61
*
WW500
NOMESCO Finland
Blood transfusion
4.6
55.6
206
480
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
32.6
55.4
73
23
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
29.2
54.7
74
26
150
Kela drug reimbursment
Dasatinib
486.6
48.5
48
*
L01XX28
ATC
[D] imatinib; oral
+∞
47.0
45
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
45.4
1255
8828
L01XE06
ATC
[U] dasatinib; systemic
434.6
43.3
43
*
XX7BT
NOMESCO Finland
Radioactive phosphorus therapy
+∞
42.8
41
*
L01XE08
ATC
[U] nilotinib; oral
+∞
42.8
41
*
R79.8
ICD-10 Finland
Other specified abnormal findings of blood chemistry
14.6
41.8
71
50
R79.9
ICD-10 Finland
Abnormal finding of blood chemistry, unspecified
16.5
40.9
66
41
D75.0
ICD-10 Finland
Familial erythrocytosis
53.1
39.6
47
9
B03XA02
ATC
darbepoetin alfa; parenteral
6.1
39.3
110
186
B28
ICPC
Limited function/disability (B)
20.1
37.9
57
29
L03AA04
ATC
NA
26.2
35.4
49
19
B74
ICPC
Malignant neoplasm blood other
35.2
35.0
45
13
328
Kela drug reimbursment
Nilotinib
+∞
33.4
32
*
B04
ICPC
Blood symptom/complaint
18.5
33.1
51
28
L01EA03
ATC
nilotinib; oral
+∞
32.4
31
*
127
Kela drug reimbursment
Transplant complication
7.0
32.2
81
119
D47.2
ICD-10 Finland
Monoclonal gammopathy of undetermined significance (MGUS)
6.0
31.2
88
151
R50.9
ICD-10 Finland
Fever, unspecified
2.1
31.1
390
2006
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
7.4
29.5
71
98
B01AC14
ATC
[U] anagrelide; oral
+∞
29.2
28
*
D75.8
ICD-10 Finland
Other specified diseases of blood and blood-forming organs
64.7
28.0
32
5
9861/3-C42.1
ICD-O-3
Acute myeloid leukemia, NOS, of bone marrow
15.8
27.7
45
29
D46.7
ICD-10 Finland
Other myelodysplastic syndromes
13.2
27.4
48
37
324
Kela drug reimbursment
Dasatinib
+∞
27.1
26
*
T86.0
ICD-10 Finland
Bone-marrow transplant rejection
50.5
25.3
30
6
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
12.0
25.2
46
39
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
25.1
765
5270
TPH00
SPAT
NA
+∞
25.0
24
*
2384A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Polycythaemia vera
+∞
25.0
24
*
B01AB05
ATC
enoxaparin; parenteral
1.6
24.8
828
5837
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
29.4
24.1
32
11
A05AA02
ATC
ursodeoxycholic acid; oral
5.8
24.0
69
122
L01AB01
ATC
busulfan; systemic
+∞
24.0
23
*
C03CA01
ATC
furosemide; systemic
1.6
22.2
831
5995
D47.0
ICD-10 Finland
Histiocytic and mast cell tumours of uncertain and unknown behaviour
80.8
21.7
24
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
21.2
321
1763
D46.9
ICD-10 Finland
Myelodysplastic syndrome, unspecified
11.0
21.1
40
37
B03XA01
ATC
erythropoietin; parenteral
7.1
20.9
51
73
C92.9
ICD-10 Finland
Myeloid leukaemia, unspecified
211.6
20.6
21
*
L01EA02
ATC
dasatinib; oral
211.6
20.6
21
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.1
19.9
228
1120
B75
ICPC
Neoplasm blood benign/unspecified
105.8
19.6
21
*
20899
ICD-8 Finland
Polycythaemia vera
+∞
18.8
18
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
4.0
18.5
75
193
C95.0
ICD-10 Finland
Acute leukaemia of unspecified cell type
30.3
18.3
24
8
R04.0
ICD-10 Finland
Epistaxis
2.1
18.3
215
1069
306
Kela drug reimbursment
Erythropoietin and darbepoetin
13.1
17.9
31
24
9875/3-C42.1
ICD-O-3
Chronic myelogenous leukemia, BCR/ABL positive of bone marrow
+∞
17.7
17
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
16.6
298
1730
D73.5
ICD-10 Finland
Infarction of spleen
16.4
16.5
26
16
L03AA02
ATC
filgrastim; parenteral
3.1
16.1
90
299
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.9
16.1
262
1473
WW200
NOMESCO Finland
Immunization
3.2
16.0
84
267
TNE20
NOMESCO Finland
Bone marrow aspiration, pelvis
18.6
16.0
24
13
I81
ICD-10 Finland
Portal vein thrombosis
9.2
15.7
32
35
PH_2
NOMESCO Finland
Other procedures on veins
+∞
15.6
15
*
170
Kela drug reimbursment
Bosutinib
+∞
15.6
15
*
S97
ICPC
Chronic ulcer skin
2.3
15.6
154
707
WW306
NOMESCO Finland
Transfer of stem cells from foreign registered donator
38.3
15.4
19
5
D72.9
ICD-10 Finland
Disorder of white blood cells, unspecified
9.8
15.2
30
31
C91.0
ICD-10 Finland
Acute lymphoblastic leukaemia [ALL]
17.8
15.1
23
13
B01AA03
ATC
warfarin; systemic
1.5
14.9
567
4033
Z01.8
ICD-10 Finland
Other specified special examinations
1.5
14.2
508
3560
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.8
14.0
90
328
J01MA12
ATC
levofloxacin; systemic
1.5
13.7
454
3127
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.0
13.7
185
974
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
13.6
135
621
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.2
13.5
142
672
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.1
13.1
153
758
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
12.6
373
2494
2387X
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[STATUS LYMPHO- ET MYELOPROLIFERATIVUS NUD]
70.2
12.6
14
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.7
12.5
263
1603
2387B
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[THROMBOCYTHAEMIA IDIOPATHICA]
+∞
12.5
12
*
D69.1
ICD-10 Finland
Qualitative platelet defects
24.4
12.5
17
7
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
3.0
12.4
72
248
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.0
12.2
163
850
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
12.1
411
2839
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
12.0
539
3948
L04AD01
ATC
ciclosporin; systemic
3.3
11.9
59
182
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.7
11.8
250
1528
SPAT1088
SPAT
Blood transfusion
7.4
11.7
27
37
B73
ICPC
Leukaemia
16.5
11.7
18
11
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
12.6
11.6
20
16
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
5.5
11.5
33
61
L01XE14
ATC
[U] bosutinib; oral
+∞
11.5
11
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.5
11.4
428
3023
WW302
NOMESCO Finland
Allogenic transfer of stem cells from relative
25.1
11.1
15
6
A02BC02
ATC
pantoprazole; systemic
1.3
11.1
1543
13599
ZX120
NOMESCO Finland
Intravenous
1.7
11.0
233
1423
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.4
11.0
88
368
M10.9
ICD-10 Finland
Gout, unspecified
1.9
10.9
169
935
C90.0
ICD-10 Finland
Multiple myeloma
3.5
10.8
48
137
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
1.7
10.8
210
1250
D68.8
ICD-10 Finland
Other specified coagulation defects
5.2
10.7
32
62
D47.7
ICD-10 Finland
Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
21.5
10.7
15
7
D75
ICD-10 Finland
Other diseases of blood and blood-forming organs
60.2
10.6
12
*
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.2
10.6
102
466
121
Kela drug reimbursment
Severe hypofunction of sexual glands
3.1
10.5
57
189
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
10.4
489
3606
B86
ICPC
OTHER HAEMATOLOGICAL ABNORMALITY
110.4
10.4
11
*
360
Kela drug reimbursment
Bosutinib
+∞
10.4
10
*
2387A
ICD-9 Finland
Neoplasm of uncertain behaviour of other and unspecified sites and tissues, Other lymphatic and haematopoietic tissues[MYELOFIBROSIS]
+∞
10.4
10
*
J01MA14
ATC
moxifloxacin; systemic
1.7
10.4
203
1210
C95.9
ICD-10 Finland
Leukaemia, unspecified
18.8
10.3
15
8
J01DB01
ATC
cefalexin; oral
1.3
10.2
1913
17511
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
1.9
9.9
143
772
H02AB06
ATC
prednisolone; systemic
1.3
9.7
1075
9100
XW000
SPAT
NA
55.2
9.6
11
*
R71
ICD-10 Finland
Abnormality of red blood cells
11.4
9.6
17
15
R72
ICD-10 Finland
Abnormality of white blood cells, not elsewhere classified
8.4
9.5
20
24
D46.2
ICD-10 Finland
Refractory anaemia with excess of blasts [RAEB]
17.6
9.4
14
8
I85.9
ICD-10 Finland
Oesophageal varices without bleeding
4.3
9.4
33
77
2051A
ICD-9 Finland
Myeloid leukaemia, Chronic
+∞
9.4
9
*
E78.0
ICD-10 Finland
Pure hypercholesterolaemia
0.7
9.1
226
3298
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.4
9.0
586
4568
I82.0
ICD-10 Finland
Budd-Chiari syndrome
24.1
8.9
12
5
C07AB07
ATC
bisoprolol; oral
1.3
8.9
1175
10151
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
1.6
8.8
266
1780
K99
ICPC
Cardiovascular disease other
2.2
8.8
82
372
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
9.5
8.8
17
18
V03AC03
ATC
deferasirox; oral
50.1
8.7
10
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
8.7
270
1821
C03DA01
ATC
spironolactone; oral
1.5
8.6
263
1769
I67.6
ICD-10 Finland
Nonpyogenic thrombosis of intracranial venous system
16.3
8.5
13
8
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.4
8.4
358
2586
C94.5
ICD-10 Finland
Acute myelofibrosis
+∞
8.3
8
*
L01EA04
ATC
bosutinib; oral
+∞
8.3
8
*
D47
ICD-10 Finland
Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue
+∞
8.3
8
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
8.3
337
2409
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
8.3
254
1708
A07AA02
ATC
nystatin; oral
1.8
8.3
148
863
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.5
8.2
60
240
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
2.2
8.2
81
379
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
1.7
8.1
165
1001
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
2.8
8.0
49
179
Y84.8
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.2
7.9
28
67
D73.1
ICD-10 Finland
Hypersplenism
13.1
7.9
13
10
N02AX02
ATC
tramadol; systemic, rectal
1.3
7.8
964
8205
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.5
7.7
58
239
D58.2
ICD-10 Finland
Other haemoglobinopathies
25.1
7.6
10
*
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
2.0
7.5
94
485
B59
ICPC
Blood and Immunity, Other therap proced/minor surg NEC
80.3
7.4
8
*
WW304
NOMESCO Finland
Transfer of stem cells from registered domestic donator
80.3
7.4
8
*
C92.2
ICD-10 Finland
Atypical chronic myeloid leukaemia, BCR/ABL- negative
+∞
7.3
7
*
373
Kela drug reimbursment
Ponatinib
+∞
7.3
7
*
H02AB09
ATC
hydrocortisone; systemic
2.5
7.3
52
208
O99.1
ICD-10 Finland
Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium
9.4
7.3
14
15
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
4.9
7.3
22
45
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
7.3
31
88
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.7
7.3
162
1006
-69
ICPC
Other reason for encounter NEC
2.0
7.2
92
478
A46
ICD-10 Finland
Erysipelas
1.4
7.2
320
2330
AA1AD
NOMESCO Finland
CT of head and brain
1.3
7.0
555
4438
D46.0
ICD-10 Finland
Refractory anaemia without ring sideroblasts, so stated
10.0
7.0
13
13
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
10.0
7.0
13
13
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
2.7
7.0
45
168
N02AA05
ATC
oxycodone; systemic
1.4
6.9
343
2541
L04AA01
ATC
[U] ciclosporin; systemic
2.8
6.9
41
148
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
6.7
6.8
16
24
M01AE01
ATC
ibuprofen; systemic, rectal
0.8
6.7
1828
19508
C92.7
ICD-10 Finland
Other myeloid leukaemia
22.6
6.7
9
*
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.3
6.7
31
95
D04.3
ICD-10 Finland
Carcinoma in situ: Skin of other and unspecified parts of face
2.3
6.6
56
243
J02AC03
ATC
voriconazole; systemic
7.8
6.6
14
18
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
12.3
6.6
11
9
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.5
6.5
219
1508
R51.80
ICD-10 Finland
Headache
1.4
6.4
260
1855
C92.5
ICD-10 Finland
Acute myelomonocytic leukaemia
70.0
6.4
7
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
6.4
367
2794
L04AA06
ATC
mycophenolic acid; systemic
2.8
6.4
38
138
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
6.3
312
2311
L01XE24
ATC
[U] ponatinib; oral
+∞
6.3
6
*
R89.8
ICD-10 Finland
Abnormal findings in specimens from other organs, systems and tissues, other abnormal findings
26.7
6.2
8
*
B83
ICPC
Purpura/coagulation defect
26.7
6.2
8
*
XQ848
NOMESCO Finland
Dermatological photography
2.1
6.2
64
306
K93
ICPC
Pulmonary embolism
3.2
6.2
30
95
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
6.2
142
894
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
1.5
6.2
174
1150
9989/3-C42.1
ICD-O-3
Myelodysplastic syndrome, NOS, of bone marrow
7.7
6.1
13
17
R60.0
ICD-10 Finland
Localized oedema
1.4
6.1
246
1758
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.1
6.0
60
283

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013650) Neutrophils [#/volume] in Blood by Automated count
2635
15131
5.34
314.19
22.2
8.6
e9/l
5.2
4.2
21.21
2468
13129
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
849
409
27.96
307.65
1.3
1.2
u/l
29.7
45.3
0.88
703
356
(3019069) Monocytes/100 leukocytes in Blood
2498
12175
5.92
307.65
18.1
6.0
%
8.4
8.8
8.88
2432
11318
(3006504) Eosinophils/100 leukocytes in Blood
2498
12125
5.95
307.65
17.2
5.7
%
2.7
2.9
2.41
2431
11225
(3006315) Basophils [#/volume] in Blood
2558
12952
6.00
307.65
15.5
5.5
e9/l
0.1
0.0
71.11
2372
11094
(3002179) Metamyelocytes/100 leukocytes in Blood
857
2024
5.43
307.65
9.8
3.7
%
1.2
0.5
8.00
319
462
(3045142) Bone marrow Pathology biopsy report
661
270
30.65
307.65
1.3
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
2565
13220
5.87
307.65
15.8
5.6
e9/l
2.0
1.9
0.25
2417
11515
(3013115) Eosinophils [#/volume] in Blood
2586
13389
6.00
307.65
17.0
5.7
e9/l
0.2
0.2
5.53
2415
11623
(3022096) Basophils/100 leukocytes in Blood
2475
11807
5.96
307.65
17.0
5.8
%
1.0
0.7
83.58
2404
10947
(3001604) Monocytes [#/volume] in Blood
2553
12890
5.99
307.65
15.5
5.5
e9/l
0.6
0.6
1.41
2368
11026
(21494434) Karyotype in Bone marrow
568
224
30.66
307.65
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
853
2127
5.11
307.65
10.1
3.9
%
0.2
0.1
3.39
419
603
(3002030) Lymphocytes/100 leukocytes in Blood
2507
12437
5.81
307.65
17.7
5.9
%
24.9
27.1
18.29
2439
11501
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
925
229
56.57
307.65
1.1
1.1
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
1422
3261
7.08
307.65
4.2
2.4
%
1.9
1.8
2.60
1274
2863
(3042111) Morphology [Interpretation] in Bone marrow Narrative
776
441
22.96
307.65
1.5
1.5
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
935
2225
5.54
307.65
10.1
3.9
%
1.5
0.8
7.09
439
647
(3023520) Reticulocytes [#/volume] in Blood
1202
2433
7.34
307.65
4.0
2.5
e9/l
77.9
68.9
11.31
899
1866
(3026493) Urate [Moles/volume] in Serum or Plasma
1847
7050
4.87
307.65
4.8
2.7
umol/l
1534.0
5866.3
8.09
1720
6016
(42870588) Differential panel, method unspecified - Blood
2102
8990
4.95
307.65
16.0
5.5
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
2099
3156
17.64
307.65
10.0
3.8
u/l
282.5
243.4
14.67
2042
2955
(3018010) Neutrophils/100 leukocytes in Blood
2475
12249
5.61
307.65
16.0
5.7
%
60.6
57.8
25.42
2399
11377
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
1138
3741
4.18
303.08
2.8
2.6
%
22.5
22.3
0.10
1002
3182
(3025159) Blasts/100 leukocytes in Blood
791
1992
4.96
298.02
10.2
4.0
%
1.0
0.2
1.55
341
500
(3004789) Transferrin [Mass/volume] in Serum or Plasma
1156
3994
3.98
284.31
2.7
2.5
g/l
2.4
2.3
10.15
1097
3685
(3022948) Iron [Moles/volume] in Serum or Plasma
1203
4299
3.89
281.20
2.8
2.5
umol/l
13.1
12.6
1.45
1144
3970
(40760892) CBC W Ordered Manual Differential panel - Blood
1279
5382
3.30
222.29
12.8
4.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
396
703
6.29
217.27
2.7
2.4
g/l
3.3
3.6
4.53
376
667
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2324
14096
3.41
209.85
10.7
6.2
umol/l
12.2
11.7
0.91
2263
13340
(3004809) Band form neutrophils/100 leukocytes in Blood
299
460
7.07
187.94
8.7
3.2
%
1.8
1.4
1.05
231
349
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1833
10591
2.73
163.70
4.0
2.8
ug/l
160.4
141.9
0.85
1709
9664
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
148
5
312.53
146.88
7.3
1.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
470
1336
3.95
144.52
1.8
1.8
g/l
1.1
1.5
19.40
404
1146
(3021589) Normoblasts [#/volume] in Blood
1858
11417
2.51
136.60
21.7
9.7
e9/l
0.1
0.0
4.23
1663
9304
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
77
20
39.43
125.91
1.0
1.0
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
311
738
4.56
120.98
2.4
2.1
%
93.0
89.6
1.82
272
704
(3017354) Segmented neutrophils/100 leukocytes in Blood
187
290
6.79
115.88
9.1
3.2
%
65.3
56.8
3.57
109
178
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1278
7049
2.36
113.67
2.7
2.2
mg/l
4.8
3.0
21.97
1101
5961
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
248
517
5.12
112.65
5.6
3.5
%
61.1
57.6
3.03
248
517
(3008757) Leukocyte morphology finding [Identifier] in Blood
187
307
6.41
109.61
10.8
3.7
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2042
13899
2.31
107.75
8.8
6.8
mmol/l
1.2
1.2
0.08
1726
11650
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2670
20575
2.86
105.85
16.4
7.6
u/l
84.0
79.4
4.86
2603
19304
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
280
710
4.23
99.51
1.9
1.5
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
103
93
11.41
98.10
1.1
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
1379
8262
2.18
96.27
6.3
4.0
ph
7.4
7.4
3.63
279
1585
(4212803)
68
28
24.79
96.22
1.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
154
247
6.50
92.22
1.1
1.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
752
3634
2.40
86.64
5.9
5.6
mmol/l
1.0
1.0
0.27
711
3348
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1834
12622
2.07
84.97
8.0
6.0
mmol/l
1.2
1.2
4.24
1691
11342
(40758558) Short blood count panel - Blood
1142
6714
2.09
80.15
14.9
6.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
82
78
10.76
75.32
1.8
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
836
4500
2.16
72.71
4.6
3.2
mmol/l
0.8
0.8
1.54
797
4181
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
238
685
3.67
70.33
2.8
2.4
%
175.7
196.5
2.83
229
651
(3017732) Neutrophils [#/volume] in Blood
427
1735
2.69
69.85
4.9
3.2
e9/l
5.8
4.1
3.50
287
1299
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
190
477
4.17
68.03
7.3
5.2
iu/ml
868.5
669.5
0.16
26
69
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
226
656
3.63
65.87
3.5
2.9
mg/l
1.4
1.6
6.46
218
589
(3024561) Albumin [Mass/volume] in Serum or Plasma
1695
11984
1.89
65.51
6.5
4.7
g/l
35.5
35.1
2.79
1597
11110
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
95
134
7.28
64.03
7.2
3.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1094
6750
1.95
63.83
1.8
1.6
nmol/l
20.2
20.5
0.23
970
5690
(3000012) Reticulocyte production index
98
145
6.94
63.24
1.9
1.5
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
598
2957
2.26
63.24
5.3
2.6
umol/l
7.0
8.7
1.75
544
2580
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1634
11554
1.85
61.75
2.4
2.0
pmol/l
91.5
94.2
1.57
1013
5864
(3005719) IgG [Mass/volume] in Serum or Plasma
435
1892
2.51
61.45
2.8
2.8
g/l
10.0
10.6
1.51
397
1711
(3020630) Protein [Mass/volume] in Serum or Plasma
516
2440
2.33
60.45
2.7
2.6
g/l
66.5
66.3
0.19
472
2216
(3033658) Prothrombin time (PT) actual/Normal
1083
6804
1.90
58.78
5.7
3.9
%
84.1
87.9
4.64
1026
6635
(3013826) Glucose [Moles/volume] in Serum or Plasma
2065
16017
1.83
54.56
5.9
4.7
mmol/l
6.6
6.8
5.31
1991
15050
(3018677) aPTT in Platelet poor plasma by Coagulation assay
750
4272
1.99
53.73
2.9
2.0
s
31.8
29.9
10.72
708
4141
(3028026) IgM [Mass/volume] in Serum or Plasma
352
1488
2.54
52.44
1.9
1.9
g/l
1.5
1.4
0.17
319
1341
(3036489) Thrombin time
257
928
2.93
52.08
2.7
2.0
s
22.4
21.6
0.64
228
827
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
146
375
4.03
50.58
3.1
2.6
u/ml
217.0
2329.7
—
8
28
(3004588) Protein electrophoresis panel - Serum or Plasma
426
2053
2.24
46.96
2.6
2.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
894
5682
1.80
44.27
2.0
1.7
mg/l
1.2
1.4
1.06
698
4382
(3013707) Erythrocyte sedimentation rate by Westergren method
2330
19380
1.76
41.68
5.3
4.2
mm/h
12.1
13.3
2.87
2188
17816
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
49
54
9.20
40.42
1.6
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
863
5565
1.76
39.97
1.9
1.8
nmol/l
1108.0
1177.7
1.44
666
4139
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
75
144
5.31
37.19
1.7
1.5
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
75
144
5.31
37.19
1.7
1.5
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
225
924
2.54
35.27
3.3
3.4
ratio
1.6
1.7
0.01
22
73
(3034860) Kappa light chains.free [Mass/volume] in Serum
229
952
2.51
34.98
3.3
3.4
mg/l
54.2
119.9
0.54
201
766
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
229
952
2.51
34.98
3.3
3.4
mg/l
36.9
68.5
1.31
202
768
(3032080) INR in Blood by Coagulation assay
1503
11567
1.57
32.90
12.7
10.1
inr
1.4
1.3
1.15
477
3242
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
253
1150
2.30
31.64
2.8
2.4
g/l
3.5
3.8
2.56
175
831
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
253
1151
2.30
31.57
2.8
2.4
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
253
1152
2.30
31.51
2.8
2.4
g/l
6.9
7.4
3.81
180
869
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
125
399
3.22
31.25
1.3
1.4
u/ml
152.5
119.8
0.39
22
79
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
238
1076
2.31
30.12
2.8
2.4
g/l
11.0
10.3
1.31
190
915
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
237
1075
2.30
29.76
2.9
2.5
g/l
3.2
3.1
0.67
175
850
(3008536) Aspergillus sp Ab [Presence] in Serum
40
51
7.93
29.39
3.7
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
299
1515
2.07
28.42
1.3
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
130
452
2.96
28.08
1.3
1.3
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
125
427
3.01
27.86
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1073
7881
1.55
27.50
6.0
4.3
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
84
225
3.81
27.48
1.5
1.8
mg/l
3.1
4.5
4.05
79
219
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
166
667
2.57
27.18
2.3
1.5
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
73
180
4.13
26.77
2.1
2.0
%
30.9
45.2
—
10
23
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
216
988
2.27
26.55
3.1
2.5
g/l
1.3
1.0
0.58
186
854
(3024471) HLA-A [Type]
43
68
6.40
26.07
1.0
1.0
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
432
2548
1.80
25.99
6.0
7.1
mmol/l
9.9
10.4
0.89
408
2417
(40760888) Immunoglobulin light chains.free panel - Serum
172
723
2.46
25.61
3.4
3.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
159
645
2.54
25.53
2.5
1.6
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
194
864
2.33
25.38
3.1
2.3
g/l
0.0
0.0
0.06
173
794
(3049242) von Willebrand panel - Platelet poor plasma
30
6
50.44
25.24
1.8
3.3
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1092
8179
1.51
24.97
4.6
3.2
u/l
33.6
38.7
1.10
1045
7742
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
699
4745
1.61
24.82
2.3
1.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
131
491
2.74
24.64
2.5
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
41
66
6.28
24.44
1.6
1.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
181
797
2.35
24.30
3.0
2.3
g/l
0.0
0.0
0.00
162
741
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1148
8726
1.49
24.27
3.4
3.1
ng/l
2203.8
1557.2
2.12
1009
7518
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
182
808
2.33
23.98
3.0
2.3
g/l
0.0
0.0
0.00
162
742
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
197
905
2.25
23.95
2.9
2.2
g/l
38.6
37.6
1.42
168
781
(3048929) Epstein Barr virus Ab [Presence] in Serum
147
595
2.54
23.72
1.2
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
397
2344
1.79
23.68
3.3
3.9
mmol/l
1.2
1.2
2.38
344
2038
(3037756) Immunofixation for Serum or Plasma
152
626
2.50
23.65
1.7
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
357
2046
1.84
23.48
2.0
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
73
199
3.73
23.33
1.2
1.2
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
64
159
4.09
23.26
3.9
2.0
e6/l
2275.4
698.2
0.44
28
71
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
75
209
3.65
23.21
2.5
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
663
4522
1.59
22.84
1.5
1.5
g/l
2.3
2.6
1.72
426
2661
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
111
397
2.86
22.81
1.2
1.2
u/ml
315.8
268.8
0.75
74
243
(3017143) Hepatitis C virus Ab [Presence] in Serum
400
2399
1.76
22.57
1.4
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
503
3216
1.67
22.47
1.3
1.3
titre
400.0
546.5
1.44
101
692
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
439
2716
1.72
22.16
1.5
1.5
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
35
53
6.67
22.12
6.1
2.6
u/l
43.2
36.4
0.36
17
16
(3044640) Blood type and Crossmatch panel - Blood
1109
8557
1.45
20.92
5.2
2.4
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
23
22
10.52
20.90
1.3
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
74
222
3.39
20.51
3.9
2.0
e9/l
0.8
1.1
1.71
39
131
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2781
25642
1.68
20.19
27.8
15.6
mg/l
20.1
25.4
16.75
2421
20647
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
58
149
3.95
20.18
4.2
2.0
e6/l
1201.2
553.2
0.50
48
127
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
83
271
3.12
20.06
3.0
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
28
37
7.63
19.95
1.5
1.4
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
56
142
4.00
19.84
4.4
2.0
e9/l
0.2
0.2
0.21
49
127
(46236302) HLA-C [Type] by High resolution typing
25
7
35.98
19.82
1.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
25
7
35.98
19.82
1.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
25
7
35.98
19.82
1.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
25
7
35.98
19.82
1.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
25
7
35.98
19.82
1.0
1.0
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
101
378
2.73
19.10
1.1
1.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
36
66
5.51
18.83
1.3
1.1
%
72.2
88.4
1.89
21
37
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
54
141
3.88
18.39
3.6
1.6
—
—
—
0
0
(4035726)
384
2415
1.67
18.04
1.4
1.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
471
3129
1.59
17.74
2.1
1.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
83
292
2.89
17.64
3.0
1.6
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
35
67
5.27
17.49
1.3
1.4
%
77.9
85.2
0.41
21
39
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
108
438
2.52
17.41
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
100
393
2.59
17.20
1.1
1.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
73
243
3.05
17.12
3.0
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
73
243
3.05
17.12
3.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
73
243
3.05
17.12
3.0
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
45
109
4.17
16.98
4.0
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
45
109
4.17
16.98
4.0
1.7
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
168
835
2.07
16.74
3.9
3.5
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
58
170
3.46
16.72
2.1
2.0
%
71.1
71.9
0.15
53
158
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
45
111
4.10
16.58
4.0
1.7
—
—
—
0
0
(3026782) Osmolality of Urine
741
5491
1.46
16.56
3.2
2.8
mosm/kgh2o
543.3
544.2
0.04
658
4682
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
47
121
3.93
16.35
1.7
2.5
%
83.2
96.0
1.49
42
115
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
222
1227
1.87
16.27
2.1
1.9
ug/l
1.4
2.5
1.02
200
1070
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
51
140
3.69
16.21
2.0
2.7
%
34.8
39.3
0.37
13
51
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
56
165
3.44
16.03
2.1
2.0
%
16.3
14.4
0.30
23
63
(40761536) Microorganisms panel - Urine sediment
347
2191
1.66
15.99
4.4
4.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
2309
20777
1.41
15.77
38.7
18.8
%
15.6
13.8
170.92
2293
20278
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2619
24139
1.48
15.49
5.1
4.1
mmol/l
1.3
1.3
1.40
2468
21711
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
189
1010
1.93
15.36
3.8
3.0
u/ml
0.4
0.4
0.03
112
580
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1066
8513
1.38
15.33
2.5
2.1
u/l
140.4
221.7
4.39
1003
7943
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1477
12421
1.35
15.26
7.8
4.1
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
364
2356
1.62
15.16
2.1
2.2
nmol/l
398.6
370.4
1.58
337
2135
(3015377) Calcium [Moles/volume] in Serum or Plasma
1171
9509
1.37
15.12
3.6
3.4
mmol/l
2.3
2.4
3.93
1022
8165
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1058
8465
1.37
14.95
2.9
2.6
u/l
54.0
58.3
3.48
972
7777
(3037692) Legionella sp identified in Specimen by Organism specific culture
39
94
4.19
14.84
1.3
1.4
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
18
20
9.05
14.66
1.3
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
130
619
2.15
14.52
1.2
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1040
8358
1.36
14.10
3.8
3.3
e6/l
57.5
86.3
0.72
822
6476
(36304419) Bacteria [Presence] in Urine
933
7401
1.37
13.65
3.6
3.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
539
3884
1.47
13.64
2.1
2.0
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
24
41
5.89
13.52
1.3
1.2
%
78.3
70.5
0.32
12
13
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
24
41
5.89
13.52
1.3
1.2
%
77.7
75.4
0.09
12
14
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
275
1707
1.67
13.49
3.9
3.6
mmol/l
1.8
1.9
0.20
197
1256
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
286
1798
1.65
13.35
3.9
3.6
kpa
5.2
5.2
0.10
256
1653
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
841
6586
1.38
13.26
5.1
2.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
468
3302
1.49
13.14
2.0
1.8
—
—
—
0
0
(44790049)
76
299
2.58
13.12
1.7
1.4
—
—
—
0
0
(44790048)
76
299
2.58
13.12
1.7
1.4
—
—
—
0
0
(44790047)
76
299
2.58
13.12
1.7
1.4
—
—
—
0
0
(44806118)
76
299
2.58
13.12
1.7
1.4
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
132
658
2.05
13.10
1.1
1.2
titre
110.9
91.7
0.23
11
48
(3009343) pH of Capillary blood
281
1775
1.64
12.87
3.9
3.7
ph
7.4
7.4
0.09
32
223
(3041096) Erythrocytes [Presence] in Urine by Automated
850
6698
1.37
12.82
3.8
3.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
467
3312
1.48
12.76
2.0
1.7
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
59
207
2.89
12.69
1.7
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
102
466
2.23
12.66
1.6
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
452
3193
1.48
12.58
1.6
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
80
330
2.46
12.53
1.0
1.1
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
40
112
3.60
12.42
1.6
2.5
u/ml
1489.1
1239.4
0.19
40
112
(3037467) Urinalysis macro (dipstick) panel - Urine
2027
18148
1.32
12.37
4.8
4.5
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
20
31
6.49
12.36
1.3
1.8
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
81
339
2.43
12.30
1.2
1.2
u/ml
2.1
3.9
0.83
30
105
(3030467) Casts [#/volume] in Urine by Automated count
950
7662
1.34
12.20
3.7
3.2
e6/l
0.5
0.5
0.01
739
5836
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
280
1791
1.62
12.19
1.7
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
693
5324
1.39
12.13
3.4
3.1
mmol/l
2.4
2.5
1.64
608
4670
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
79
330
2.43
12.06
1.2
1.2
u/ml
4.8
5.4
0.12
38
139
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
69
271
2.58
11.99
1.2
1.2
u/l
52.8
57.2
0.29
45
188
(21494890) Protein electrophoresis panel - 24 hour Urine
75
307
2.48
11.96
2.3
2.0
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
133
692
1.96
11.74
1.5
1.5
g/l
0.2
0.2
1.10
121
655
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
49
162
3.06
11.72
1.9
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1479
12742
1.30
11.69
5.2
5.2
estimate
0.0
0.0
0.50
392
2395
(40765089) Chromosome analysis panel - Blood by G-banded
19
30
6.37
11.54
1.1
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
381
2646
1.50
11.49
2.2
2.1
g/l
0.2
0.2
0.69
342
2452
(3028433) Virus identified in Specimen by Culture
33
86
3.87
11.36
1.3
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
748
5873
1.36
11.32
3.0
2.6
e6/l
4.8
5.3
0.54
675
5162
(3009261) Glucose [Presence] in Urine by Test strip
1492
12904
1.29
11.31
3.9
3.9
estimate
0.0
0.0
1.08
389
2325
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
171
977
1.79
11.30
2.4
2.2
ug/l
265.7
745.1
1.49
163
918
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1811
16064
1.30
11.30
3.7
3.2
u/l
61.2
52.9
2.99
1713
14738
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
135
717
1.92
11.23
1.5
1.5
g/l
1.1
1.2
1.46
125
677
(3035350) Ketones [Presence] in Urine by Test strip
1473
12729
1.29
11.20
3.9
3.8
estimate
0.0
0.0
0.00
400
2364
(4306422)
77
330
2.37
11.13
1.1
1.2
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1268
10752
1.30
11.12
4.3
3.9
ng/l
45.3
99.5
0.72
997
7869
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
173
997
1.78
11.10
2.6
2.7
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
126
657
1.96
11.07
1.8
1.9
mg/l
15.9
11.9
1.23
109
603
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
67
272
2.49
10.90
2.9
2.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
83
376
2.24
10.57
1.5
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
44
5.03
10.51
1.4
1.8
e6/l
61.4
195.0
2.16
14
18
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
73
316
2.34
10.35
1.6
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
29
74
3.95
10.29
6.8
2.1
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
2822
26825
1.46
10.23
29.2
18.3
mmol/l
139.4
139.6
3.62
2779
26128
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
255
1666
1.58
10.15
6.9
7.0
mmol/l
24.7
24.9
0.28
255
1656
(3019225) pH of Specimen
404
2906
1.45
10.15
5.3
4.4
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
42
139
3.05
10.07
1.1
1.1
u/l
118.8
83.4
1.53
30
102
(3018095) Leukocytes [#/volume] in Urine
1141
9639
1.29
10.00
4.3
3.8
e6/l
113.8
117.3
0.05
865
6935
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
23
50
4.63
10.00
1.6
1.3
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
42
140
3.03
9.95
1.1
1.1
u/l
39.7
26.1
0.93
31
100
(3000494) Fungus identified in Specimen by Culture
419
3055
1.43
9.77
1.9
1.4
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2824
26888
1.45
9.74
30.9
18.5
mmol/l
4.0
4.0
6.13
2776
26150
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
229
1474
1.60
9.72
2.8
3.2
pmol/l
4.4
4.4
0.16
187
1280
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
150
863
1.77
9.72
1.4
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
72
320
2.28
9.63
1.0
1.1
%
111.7
115.8
0.48
66
291
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1271
10933
1.27
9.49
2.6
2.2
nmol/l
78.3
78.6
0.15
1135
9623
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2126
19457
1.28
9.40
4.3
4.0
pmol/l
15.1
14.9
1.96
1949
17466
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
82
391
2.13
9.25
1.6
1.5
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
27
71
3.83
9.22
1.2
1.1
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
181
1114
1.66
9.20
2.1
1.8
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2505
23451
1.32
9.15
5.3
4.8
mu/l
2.0
2.1
0.29
2345
21172
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
20
42
4.79
9.06
1.3
1.5
—
—
—
0
0
(40768443) Skin Pathology biopsy report
187
1166
1.64
9.04
1.3
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
56
229
2.47
9.03
1.3
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
85
416
2.07
8.97
1.6
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
100
520
1.95
8.92
1.2
1.4
mmol/l
57.1
60.7
0.47
81
412
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
192
1210
1.62
8.90
2.9
1.9
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
114
626
1.85
8.64
1.6
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
397
2932
1.40
8.57
3.8
3.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
22
53
4.17
8.45
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
76
365
2.11
8.45
1.5
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2577
24293
1.32
8.44
26.6
14.7
ml/min/173m2
76.0
76.9
1.27
2275
20127
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
26
71
3.68
8.44
1.0
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2638
24952
1.34
8.44
5.6
4.6
mmol/l
1.3
1.5
60.20
2495
22645
(21494814) CD8 cells/100 lymphocytes in Specimen
31
96
3.25
8.34
2.5
2.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2656
25161
1.34
8.30
5.6
4.6
mmol/l
4.2
4.6
81.16
2530
22995
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
310
2203
1.45
8.28
3.2
2.7
ml/min/173m2
56.5
62.8
2.96
184
914
(40767503) Oxygen content in Capillary blood by calculation
110
607
1.84
8.22
2.6
2.5
%
16.3
16.0
0.20
56
312
(3027315) Oxygen [Partial pressure] in Blood
116
652
1.81
8.17
4.6
4.8
kpa
8.2
8.4
0.59
116
642
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
17
34
5.02
8.13
1.1
1.4
nmol/l
8.9
282148.8
0.49
12
28
(3001964) Herpes simplex virus Ag [Presence] in Specimen
27
78
3.48
8.09
1.4
1.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
115
648
1.80
8.04
3.5
3.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
39
142
2.77
7.96
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
22
56
3.95
7.87
1.1
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
114
646
1.79
7.83
4.6
4.8
mmol/l
2.7
2.7
0.04
77
451
(3013290) Carbon dioxide [Partial pressure] in Blood
114
647
1.79
7.80
4.6
4.8
kpa
5.0
5.1
0.21
114
638
(4268621)
52
221
2.38
7.77
2.1
2.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1127
9732
1.24
7.67
4.2
4.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
111
631
1.79
7.56
2.9
2.9
kpa
7.7
7.9
1.02
105
578
(3022313) Gas panel - Capillary blood
195
1287
1.55
7.47
4.4
3.8
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
98
540
1.84
7.40
2.9
2.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
433
3326
1.35
7.30
7.2
7.0
kpa
5.0
5.1
1.92
415
3164
(3027801) Oxygen [Partial pressure] in Arterial blood
433
3326
1.35
7.30
7.2
7.0
kpa
11.9
12.0
0.12
413
3164
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
77
395
1.97
7.21
1.1
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
169
1090
1.58
7.17
4.4
4.0
mmol/l
24.4
24.9
1.08
152
1004
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
303
2204
1.41
7.12
3.5
3.8
ng/l
88.5
94.1
0.55
261
1872
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
26
80
3.27
7.10
1.0
1.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
358
2690
1.37
6.94
3.7
3.5
kpa
5.8
5.9
0.57
348
2608
(3011985) Renin [Units/volume] in Plasma
68
339
2.03
6.91
1.3
1.4
mu/l
66.9
53.0
0.17
57
299
(3031040) Bacteria [#/volume] in Urine by Automated count
1916
17602
1.22
6.91
5.1
4.8
e6/l
2824.6
2217.4
0.09
23
272
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
21
57
3.70
6.91
1.8
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
356
2679
1.37
6.84
3.7
3.5
mmol/l
1.7
2.0
0.92
291
2150
(3029937) Albumin [Presence] in Urine by Test strip
823
6935
1.25
6.81
4.2
4.3
estimate
0.0
0.0
0.88
381
2284
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
331
2467
1.38
6.75
2.4
2.5
u/l
32.6
57.8
0.71
288
2116
(3047189) Immunofixation for 24 hour Urine
36
138
2.63
6.71
1.9
1.5
—
—
—
0
0
(3036603) Volume of Urine
42
174
2.43
6.68
1.8
1.4
ml
1611.5
1762.9
—
8
38
(3015171) Extractable nuclear Ab [Units/volume] in Serum
145
918
1.61
6.67
1.2
1.2
u/ml
0.2
1.0
—
8
80
(3016502) Oxygen saturation in Arterial blood
388
2971
1.35
6.67
7.6
7.4
%
95.1
95.5
0.51
375
2856
(3003396) Base excess in Arterial blood by calculation
427
3317
1.33
6.66
7.4
7.0
mmol/l
1.1
1.1
0.05
330
2583
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2826
27191
1.35
6.61
23.6
10.9
u/l
25.4
25.9
1.00
2770
26110
(40768797) Stomach Pathology biopsy report
474
3743
1.31
6.58
1.3
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
20
55
3.65
6.47
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
41
171
2.42
6.44
1.5
1.5
u/l
10.4
6.7
0.21
21
83
(3014111) Lactate [Moles/volume] in Serum or Plasma
336
2531
1.37
6.41
6.5
6.5
mmol/l
1.5
1.4
0.78
324
2439
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2692
25748
1.30
6.39
6.1
5.2
mmol/l
2.4
2.7
58.13
2556
23400
(3015235) Bicarbonate [Moles/volume] in Capillary blood
121
743
1.65
6.30
3.1
3.2
mmol/l
25.1
25.1
0.00
112
641
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
164
1084
1.54
6.28
1.7
1.8
u/l
39.9
38.5
0.36
136
946
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
669
5551
1.26
6.27
4.1
3.9
ng/l
592.9
584.2
0.01
544
4551
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
9
5
18.04
6.26
1.0
1.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
316
2367
1.37
6.25
7.7
7.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
992
8599
1.22
6.21
3.4
3.4
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
43
187
2.32
6.17
1.1
1.2
titre
125.0
115.3
—
6
34
(3019060) Gas panel - Arterial blood
267
1951
1.40
6.13
4.9
4.7
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
62
314
1.99
6.08
1.2
1.5
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
490
3942
1.29
5.89
32.0
26.7
inr
1.5
1.4
0.81
77
555
(3036048) Francisella tularensis Ab [Titer] in Serum
19
54
3.53
5.88
1.1
1.1
—
—
—
0
0
(3010421) pH of Blood
121
766
1.60
5.62
4.5
4.5
ph
7.4
7.4
0.22
114
637
(3016038) Potassium [Moles/volume] in Urine
41
183
2.26
5.57
1.1
1.2
mmol/l
35.4
33.2
0.26
36
158
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
213
1522
1.43
5.57
8.5
9.0
mmol/l
24.4
24.4
0.01
203
1424
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
37
158
2.36
5.56
1.3
1.1
u/l
103.5
82.1
0.50
32
139
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
61
318
1.94
5.54
1.1
1.4
pmol/l
292.2
291.6
0.00
48
244
(3014576) Chloride [Moles/volume] in Serum or Plasma
449
3613
1.28
5.37
7.8
6.6
mmol/l
104.0
104.2
0.50
442
3527
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2521
24044
1.23
5.36
6.4
6.2
mmol/mol
38.5
40.4
23.17
2375
22020
(3028308) Erythrocytes [#/volume] in Pleural fluid
63
336
1.89
5.36
1.3
1.4
e6/l
113387.5
92817.7
0.14
38
198
(3020393) Adenovirus Ag [Presence] in Stool
10
18
5.57
5.32
1.1
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
18
53
3.41
5.30
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
191
1356
1.43
5.19
1.4
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
37
164
2.27
5.14
4.9
3.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
535
4420
1.25
5.13
3.4
3.0
e6/l
1.8
2.4
1.33
283
2432
(3003434) Protein [Mass/volume] in Pleural fluid
73
414
1.78
5.13
1.3
1.5
g/l
31.5
32.2
0.19
66
374
(3003327) Ova and parasites identified in Stool by Light microscopy
113
721
1.59
5.11
1.7
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
21
70
3.01
5.10
1.0
1.1
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
15
40
3.76
5.09
2.3
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
8
6
13.36
5.08
2.0
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
62
1096
0.56
5.06
1.5
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
31
128
2.44
5.04
1.1
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
82
487
1.70
4.92
2.3
3.1
—
—
—
0
0
(3044889) 12 lead EKG panel
1991
18634
1.18
4.90
4.6
4.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
21
72
2.93
4.87
1.3
1.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2385
22687
1.21
4.86
33.1
16.7
%
39.0
39.2
0.42
1516
15159
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
186
1333
1.42
4.82
4.3
3.7
mmol/l
24.1
24.2
0.13
175
1191
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
31
131
2.38
4.81
1.9
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
31
131
2.38
4.81
1.9
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
38
177
2.16
4.71
1.7
1.3
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
66
378
1.76
4.53
1.3
1.4
e6/l
1913.2
1808.7
0.08
46
274
(40757373) Influenza virus identified in Isolate
20
70
2.87
4.49
1.3
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
27
111
2.44
4.46
2.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
114
1684
0.66
4.43
1.8
1.8
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
43
217
2.00
4.36
1.0
1.1
—
—
—
0
0
(3022145) Colonoscopy Study observation
364
2933
1.27
4.31
1.2
1.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
10
22
4.56
4.30
1.0
1.0
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
31
3.88
4.25
1.4
1.0
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
73
439
1.68
4.23
1.1
1.3
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
37
179
2.08
4.21
1.5
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
112
748
1.52
4.20
1.5
1.6
iu/ml
0.6
8.6
0.54
20
160
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
11
27
4.08
4.16
2.8
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
27
4.08
4.16
3.0
1.9
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
11
27
4.08
4.16
2.8
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
11
27
4.08
4.16
2.8
1.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1172
10608
1.17
4.12
2.4
2.2
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
8
10
8.02
4.06
3.4
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
36
175
2.07
4.05
1.8
1.3
—
—
—
0
0
(3013512) EKG study
932
8298
1.17
4.02
4.5
4.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
90
580
1.57
3.98
2.2
2.9
umol/l
36.9
37.0
0.01
72
484
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
116
792
1.48
3.94
1.9
1.7
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
61
358
1.72
3.89
2.6
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2603
25107
1.20
3.89
5.2
4.9
mmol/l
6.0
6.0
0.82
2381
22606
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
21
82
2.57
3.88
2.1
1.9
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
280
2214
1.29
3.86
3.0
2.9
kpa
4.6
4.6
0.18
273
2141
(3001686) Cold agglutinin [Titer] in Serum or Plasma
16
54
2.97
3.84
1.5
1.4
titre
—
106.0
—
0
11
(3025468) Yersinia sp identified in Specimen by Organism specific culture
60
352
1.72
3.84
2.6
1.4
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
32
152
2.12
3.84
1.3
1.2
u/l
20.7
16.6
0.48
27
131
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
43
228
1.90
3.82
1.1
1.1
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
164
1201
1.39
3.81
4.6
5.3
%
1.9
1.6
1.46
152
1123
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
9
15
6.01
3.81
3.0
4.9
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
43
773
0.55
3.81
1.6
1.7
mg/l
5.5
3.6
0.35
38
551
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
29
3.80
3.80
1.5
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
21
83
2.54
3.79
2.3
2.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
61
361
1.70
3.79
2.6
1.4
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
320
2582
1.27
3.76
3.5
3.0
ng/l
224.0
220.7
0.05
296
2351
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
27
122
2.22
3.67
1.2
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
31
149
2.09
3.62
1.0
1.1
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
335
2737
1.25
3.55
8.4
7.8
g/l
118.2
121.2
1.43
324
2637
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
108
744
1.47
3.54
1.7
1.8
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
361
1.67
3.53
1.7
1.6
g/l
0.8
0.8
0.26
45
273
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
8
13
6.17
3.50
1.0
1.5
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
39
208
1.89
3.44
1.4
2.6
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
25
113
2.22
3.41
1.5
5.8
—
61.7
—
0
27
(3032057) Clostridioides difficile [Presence] in Stool
18
70
2.58
3.38
2.7
1.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
52
305
1.72
3.37
1.1
1.1
—
—
—
0
0
(3035880) pH of Pleural fluid
34
175
1.95
3.33
1.3
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
58
352
1.66
3.32
2.7
1.4
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
74
478
1.56
3.30
1.6
1.3
u/l
12.7
10.3
0.80
66
385
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
548
4739
1.19
3.29
3.2
2.8
e6/l
0.9
1.2
1.09
297
2730
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
57
346
1.66
3.27
1.4
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
58
354
1.65
3.26
2.7
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
214
1674
1.30
3.24
1.7
1.5
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
61
378
1.63
3.24
1.3
1.3
nmol/l
0.2
0.4
—
5
25
(3048689) Calprotectin [Mass/mass] in Stool
337
2785
1.23
3.23
2.2
2.2
ug/g
190.5
155.5
0.56
268
2169
(3001893) Eosinophils/100 leukocytes in Pleural fluid
22
97
2.28
3.19
1.5
1.5
%
3.8
3.2
0.09
22
81
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
58
357
1.64
3.17
2.6
1.4
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
20
85
2.36
3.15
1.3
1.5
—
2024630.0
—
0
5
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
33
172
1.93
3.14
1.1
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
65
413
1.59
3.13
1.2
1.2
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
50
298
1.69
3.09
1.3
1.3
mosm/kgh2o
272.0
277.3
0.93
42
223
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
12
39
3.08
3.09
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
53
321
1.66
3.09
1.3
1.6
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
6
8
7.51
3.05
4.2
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
85
579
1.48
3.00
1.4
1.3
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
50
301
1.67
2.99
3.4
3.7
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
49
295
1.67
2.93
1.3
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
78
526
1.50
2.90
1.1
1.2
—
9.2
—
0
6
(3017704) Immunofixation for Urine
32
170
1.89
2.90
2.4
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
91
633
1.45
2.90
2.2
2.2
g/l
131.3
127.9
0.41
70
459
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
89
617
1.46
2.89
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
89
617
1.46
2.89
1.6
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
90
628
1.45
2.83
1.2
1.2
u/ml
1.8
3.8
—
5
59
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
28
144
1.95
2.79
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
28
144
1.95
2.79
1.0
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
91
638
1.44
2.79
1.2
1.2
u/ml
3.9
7.6
—
8
112
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
83
572
1.46
2.79
1.4
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
63
410
1.55
2.77
2.4
2.7
—
—
—
0
0
(44806071)
9
23
3.92
2.77
1.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
32
173
1.86
2.76
2.7
2.9
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
155
1189
1.32
2.75
4.8
5.3
%
0.9
0.9
0.64
143
1114
(3026250) Tacrolimus [Mass/volume] in Blood
20
91
2.21
2.73
27.6
30.0
ug/l
6.9
7.4
0.39
15
79
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1494
14023
1.12
2.72
2.7
2.6
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
13
48
2.72
2.71
2.5
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
16
66
2.43
2.70
1.1
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
60
2.51
2.70
1.0
1.8
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
38
220
1.74
2.64
1.6
1.8
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
75
513
1.47
2.63
1.2
1.2
u/ml
1.3
8.0
—
5
38
(3023323) Follitropin [Units/volume] in Serum or Plasma
95
681
1.41
2.60
1.4
1.3
iu/l
26.8
31.3
0.81
85
578
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
169
1323
1.29
2.60
4.0
3.8
%
46.4
48.1
0.38
164
1307
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
459
3990
1.18
2.59
1.2
1.2
u/ml
10.3
13.0
0.40
156
1492
(40759836) Histone Ab [Presence] in Serum by Immunoblot
32
178
1.81
2.55
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
32
178
1.81
2.55
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
32
178
1.81
2.55
1.1
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
582
5165
1.16
2.52
1.3
1.2
u/ml
2.1
1.5
0.35
109
1307
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
19
88
2.17
2.50
2.2
2.1
e6/l
1335.8
23277.4
0.54
13
50
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
477
4174
1.17
2.48
1.3
1.3
iu/ml
26.7
38.0
1.51
153
1317
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
32
181
1.78
2.43
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
32
181
1.78
2.43
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
32
181
1.78
2.43
1.1
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
119
1561
0.75
2.41
1.4
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
180
1438
1.27
2.39
3.2
3.2
mmol/l
24.7
25.3
1.64
172
1390
(36660697) Celiac disease serology panel - Serum
227
1864
1.23
2.37
1.2
1.2
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
39
236
1.66
2.35
1.6
1.6
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
102
755
1.36
2.34
1.2
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
26
140
1.86
2.31
1.7
2.4
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
9
28
3.22
2.30
2.4
4.4
—
—
—
0
0
(4062490)
38
231
1.65
2.26
1.2
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
21
106
1.99
2.25
1.2
1.2
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
43
271
1.59
2.23
1.1
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
26
142
1.84
2.23
2.6
3.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
102
762
1.35
2.23
1.2
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
55
367
1.51
2.22
2.5
2.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
38
603
0.63
2.21
1.2
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
27
150
1.81
2.20
1.1
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
220
1820
1.22
2.16
8.2
6.8
mmol/l
24.1
24.6
0.87
206
1694
(3027923) C peptide [Moles/volume] in Serum or Plasma
26
144
1.81
2.14
1.2
1.4
nmol/l
1.3
1.2
0.12
17
113
(42529406) Shigella sp [Presence] in Stool by Culture
102
768
1.34
2.13
1.2
1.2
—
—
—
0
0
(4198724)
13
55
2.37
2.12
1.3
1.5
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
42
267
1.58
2.11
1.4
1.7
—
1220.0
—
0
8
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
23
123
1.88
2.11
1.1
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
19
95
2.01
2.10
1.4
1.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
8
25
3.21
2.09
1.6
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
16
75
2.14
2.08
1.1
1.3
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
183
1.70
2.07
1.5
1.5
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
17
82
2.08
2.06
1.1
1.3
ug/l
51.4
455.3
—
10
40
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
79
576
1.38
2.03
1.2
1.1
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
46
302
1.53
2.03
1.3
1.5
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
8
26
3.08
2.01
2.4
2.7
u/field
0.5
0.8
—
8
26
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
21
111
1.90
2.00
2.0
2.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
35
216
1.63
2.00
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
107
820
1.32
2.00
1.4
1.5
ug/g
285.8
274.9
0.24
65
476
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
49
328
1.50
1.98
1.2
1.3
nmol/l
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
47
312
1.51
1.98
1.2
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
56
386
1.46
1.97
2.4
2.5
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
188
1548
1.23
1.96
10.3
9.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
39
250
1.57
1.92
1.2
1.1
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
20
106
1.89
1.90
2.0
2.8
umol/l
66.8
104.5
0.58
11
58
(3026389) Candida sp identified in Specimen by Organism specific culture
52
356
1.47
1.90
1.5
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
25
143
1.75
1.88
2.1
2.5
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
36
228
1.59
1.87
1.1
1.4
g/l
2.4
3.0
1.12
24
158
(3024139) IgG subclass 3 [Mass/volume] in Serum
36
228
1.59
1.87
1.1
1.4
g/l
0.4
0.4
0.12
24
158
(3027135) IgG subclass 1 [Mass/volume] in Serum
36
228
1.59
1.87
1.1
1.4
g/l
6.5
7.2
0.48
25
158
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
9
34
2.65
1.86
1.1
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
755
6943
1.11
1.85
1.6
1.6
mmol/l
1.5
1.4
2.15
648
5765
(3023487) Leukocytes [#/volume] in Peritoneal fluid
19
100
1.91
1.85
2.2
2.3
e6/l
560.4
776.1
0.43
13
76
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
27
159
1.70
1.85
1.6
1.5
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
6
17
3.53
1.83
1.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
5
12
4.17
1.82
1.0
1.0
s
46.1
35.2
—
5
12
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
10
222
0.45
1.82
1.4
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
27
160
1.69
1.81
1.6
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
183
0.44
1.80
1.5
1.5
—
—
—
0
0
(3006270) Folate [Moles/volume] in Blood
36
231
1.56
1.78
1.4
1.2
nmol/l
360.7
358.2
0.02
31
197
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
27
161
1.68
1.78
3.3
1.7
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
44
297
1.49
1.75
5.0
3.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
6
18
3.34
1.74
1.7
1.0
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
26
155
1.68
1.72
1.7
2.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
178
1481
1.21
1.71
3.6
3.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
176
0.45
1.69
1.5
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
176
0.45
1.69
1.5
1.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
24
141
1.71
1.68
1.2
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
181
1513
1.21
1.66
2.4
2.5
—
—
—
0
0
(3000919) Neutrophils/100 leukocytes in Pleural fluid
17
90
1.89
1.65
1.6
1.4
%
17.1
23.2
0.52
17
82
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
22
127
1.74
1.64
1.3
1.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
723
6677
1.11
1.63
1.5
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
80
609
1.32
1.62
2.3
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
209
0.48
1.58
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
2853
28110
1.15
1.56
47.6
22.9
e9/l
384.2
245.7
288.69
2808
27323
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
64
2.04
1.54
1.8
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
79
606
1.31
1.53
2.1
1.8
nmol/l
40.4
42.1
0.28
74
576
(3024731) MCV [Entitic volume]
2853
28117
1.14
1.52
47.3
22.9
fl
93.9
91.4
30.66
2827
27638
(3035941) MCH [Entitic mass]
2853
28118
1.14
1.51
47.2
22.8
pg
30.7
30.4
3.41
2827
27637
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
27
2.60
1.51
6.1
2.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
2853
28120
1.14
1.50
47.5
22.9
e12/l
4.4
4.4
2.99
2797
27236
(40761511) CBC panel - Blood by Automated count
2688
26399
1.12
1.50
25.0
14.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
12
58
2.07
1.49
1.4
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
209
1791
1.18
1.49
2.7
3.0
g/l
125.7
127.9
0.63
199
1741
(3000963) Hemoglobin [Mass/volume] in Blood
2853
28126
1.14
1.47
47.8
23.1
g/l
131.0
134.3
19.47
2826
27654
(3010813) Leukocytes [#/volume] in Blood
2853
28126
1.14
1.47
47.6
23.0
e9/l
8.9
6.8
28.33
2799
27243
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
28
179
1.57
1.45
2.0
1.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
96
763
1.27
1.44
4.3
4.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
13
66
1.97
1.43
1.4
1.5
ug/l
0.5
0.3
—
8
35
(3035637) Corticotropin [Mass/volume] in Plasma
43
304
1.42
1.40
1.6
1.5
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
7
29
2.42
1.39
5.4
5.6
ug/min
61.3
65.8
—
7
24
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
9
41
2.20
1.37
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
385
3470
1.12
1.36
5.0
4.7
%
31.6
33.1
2.06
302
2233
(3050794) Legionella sp Ab [Presence] in Serum
6
23
2.61
1.36
1.0
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
43
306
1.41
1.36
1.7
2.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
658
6104
1.10
1.36
1.6
1.7
pmol/l
21022097.8
26562929.9
0.10
509
4992
(3003338) MCHC [Mass/volume]
2034
20904
0.93
1.33
42.4
20.3
g/l
326.4
331.9
54.88
2021
20725
(3002256) Pathology report gross observation
387
3498
1.12
1.31
1.3
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
25
160
1.57
1.31
1.4
1.5
g/l
1.0
1.0
0.02
25
160
(3029396) Erythrocyte agglutination [Presence] in Blood
6
24
2.50
1.30
1.7
2.8
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
8
34
2.36
1.29
1.5
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
26
169
1.54
1.28
2.3
2.1
min
491.5
487.9
0.06
15
124
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
8
35
2.29
1.26
1.0
1.1
—
—
—
0
0
(3026480) Teichoate Ab [Titer] in Serum
6
25
2.40
1.24
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
498
5405
0.91
1.23
2.8
3.1
ug/l
0.8
0.8
0.22
340
3719
(3040151) Glucose [Moles/volume] in Capillary blood
43
313
1.38
1.22
8.4
6.8
mmol/l
7.5
7.6
0.06
36
265
(3004775) Volume in Urine collected for unspecified duration
33
229
1.45
1.21
2.4
2.3
ml
690.4
628.0
0.37
19
149
(3017446) Testosterone [Moles/volume] in Serum or Plasma
207
1807
1.16
1.21
2.9
2.2
nmol/l
12.8
12.7
0.00
187
1573
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
369
3345
1.12
1.20
1.4
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
148
1.56
1.20
1.2
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
146
1243
1.18
1.17
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
15
249
0.60
1.17
1.3
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
35
249
1.41
1.14
1.2
1.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
289
2592
1.13
1.14
1.6
1.8
%
1.5
1.5
0.12
243
2226
(3019977) pH of Arterial blood
23
150
1.54
1.14
3.2
2.7
ph
7.4
7.4
—
9
51
(3005322) IgE [Units/volume] in Serum or Plasma
163
1408
1.17
1.11
1.3
1.3
u/ml
192.2
218.6
0.22
153
1291
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
77
620
1.25
1.09
1.2
1.1
u/ml
20.1
6.0
—
7
58
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
59
1.87
1.07
1.1
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
74
1.76
1.06
3.2
1.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
52
1.93
1.06
1.1
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
18
113
1.60
1.05
1.1
1.7
ug/l
2.7
5.9
0.66
11
89
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
25
170
1.47
1.04
1.4
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
8
148
0.54
1.03
1.1
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
85
698
1.22
1.03
3.4
3.2
nmol/l
0.8
0.8
0.41
63
542
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
26
179
1.46
1.02
1.3
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
13
75
1.74
1.02
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
48
368
1.31
1.01
1.4
1.9
u/l
32305.2
2024.4
1.00
13
144
(3011397) Hemoglobin [Presence] in Urine by Test strip
658
6186
1.08
1.01
3.5
3.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
10
53
1.89
1.01
1.4
2.0
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
123
1049
1.18
1.00
2.4
3.2
u/ml
414.7
4792.2
0.94
105
884
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
32
231
1.39
0.99
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
61
486
1.26
0.97
1.2
1.2
miu/ml
252.2
215.2
0.23
19
193
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
50
1.80
0.96
1.0
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
78
945
0.82
0.96
1.7
1.7
—
—
—
0
0
(3020891) Body temperature
136
1176
1.16
0.95
5.7
4.4
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
7
37
1.89
0.94
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
49
382
1.29
0.93
1.2
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
104
881
1.19
0.93
5.4
3.9
mmol/l
4.0
3.9
1.07
99
819
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
30
217
1.39
0.93
5.1
4.9
u/ml
47.5
40.9
—
10
57
(1001926) Buprenorphine [Presence] in Urine by Screen method
46
357
1.29
0.91
1.3
1.8
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
28
2.14
0.91
1.7
1.2
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
13
78
1.67
0.91
2.6
2.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
22
151
1.46
0.90
6.9
6.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
11
63
1.75
0.90
2.7
2.4
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
289
2635
1.11
0.89
2.3
2.4
ug/l
5.2
7.1
2.04
229
2294
(3016879) Cocaine [Presence] in Urine
54
430
1.26
0.88
1.3
2.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
10
56
1.79
0.87
1.2
1.6
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
68
557
1.23
0.87
1.5
1.4
e6/l
28.0
28.0
0.00
54
425
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
68
557
1.23
0.87
1.6
1.4
e6/l
947.6
1349.7
0.18
57
449
(3024891) Influenza virus A+B Ag [Presence] in Specimen
77
640
1.21
0.86
1.4
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
165
1461
1.14
0.85
1.2
1.2
iu/ml
92.6
141.0
1.25
58
521
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
21
298
0.70
0.85
1.0
1.3
mmol/l
7.9
7.5
0.18
16
217
(3004716) Salmonella sp identified in Stool by Organism specific culture
126
1096
1.16
0.84
1.3
1.3
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
32
239
1.34
0.84
1.3
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
11
65
1.69
0.82
1.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
6
32
1.88
0.81
1.5
1.2
nmol/l
29.8
36.9
—
6
26
(3030981) Hyaline casts [#/volume] in Urine by Automated count
165
1467
1.13
0.81
3.3
2.9
e6/l
0.3
0.3
0.21
160
1436
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
190
1705
1.12
0.80
2.6
2.4
au/ml
26.4
23.9
—
9
76
(3025018) Bordetella pertussis Ab [Titer] in Serum
17
114
1.49
0.79
1.1
1.3
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
6
33
1.82
0.79
1.0
1.2
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
14
90
1.56
0.78
1.2
1.2
g/l
38.1
38.8
—
7
45
(1617658) Protocol used for examination of sentinel lymph nodes
15
222
0.67
0.77
1.0
1.0
—
—
—
0
0
(3039000) Anion gap in Blood
77
649
1.19
0.77
7.1
7.2
mmol/l
11.8
11.2
0.87
68
578
(3018572) Chloride [Moles/volume] in Blood
77
649
1.19
0.77
7.1
7.2
mmol/l
105.2
105.2
0.04
68
578
(3012565) Volume of 24 hour Urine
19
132
1.44
0.76
1.7
2.5
ml
2132.6
1876.4
0.46
19
113
(3037121) Protein [Mass/volume] in Urine
112
976
1.15
0.75
2.9
3.0
g/l
0.5
0.3
0.89
51
367
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
331
3069
1.09
0.75
3.0
4.0
ug/l
13.9
22.6
0.49
253
2522
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
5
24
2.08
0.74
1.4
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
50
405
1.24
0.74
1.3
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
719
7529
0.94
0.74
3.8
4.5
%
22.4
21.8
0.47
359
3806
(3023410) Appearance of Cerebral spinal fluid
33
254
1.30
0.73
1.8
1.5
—
—
—
0
0
(3000492) Spirometry study
252
2311
1.10
0.73
1.6
1.5
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
5
25
2.00
0.72
3.4
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
5
25
2.00
0.72
6.8
5.9
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
36
457
0.79
0.72
1.6
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
56
676
0.83
0.72
1.0
1.1
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
7
40
1.75
0.71
1.4
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
143
1.40
0.70
1.2
1.1
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
41
1.71
0.70
1.4
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
7
42
1.67
0.68
1.1
1.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
34
267
1.28
0.66
1.6
1.4
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
5
28
1.79
0.66
1.8
1.3
—
640.5
—
0
9
(4034850)
74
862
0.86
0.65
18.1
10.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
40
322
1.25
0.65
1.5
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
24
180
1.34
0.65
1.1
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
8
49
1.63
0.62
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
152
0.66
0.61
1.5
1.6
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
61
519
1.18
0.59
1.4
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
23
0.00
0.58
0.0
1.8
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
8
53
1.51
0.58
1.1
1.1
—
6.0
—
0
8
(3000764) Benzodiazepines [Presence] in Urine
55
465
1.19
0.57
1.4
1.9
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
6
35
1.72
0.57
1.0
1.2
umol/24h
2.6
1.9
—
6
35
(3051593) INR in Capillary blood by Coagulation assay
20
149
1.34
0.57
10.1
13.5
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
21
158
1.33
0.57
1.0
1.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
15
207
0.72
0.56
1.0
1.0
ng/l
888.8
689.2
—
10
132
(3027008) Opiates [Presence] in Urine
55
467
1.18
0.55
1.4
1.9
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
15
206
0.73
0.55
1.0
1.0
ng/l
38.1
46.9
—
10
130
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
15
206
0.73
0.55
1.0
1.0
ng/l
277.3
322.7
—
10
134
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
35
284
1.23
0.55
1.2
1.0
u/ml
3.5
2.2
—
9
105
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
22
168
1.31
0.55
1.8
1.3
u/ml
3.0
1.3
0.27
17
86
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
79
692
1.15
0.54
1.3
1.2
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
9
60
1.50
0.54
1.0
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
55
469
1.18
0.53
1.3
1.9
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
6
40
1.50
0.51
1.5
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
11
75
1.47
0.50
1.0
1.0
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
13
179
0.73
0.50
1.0
1.5
—
72.4
—
0
12
(40768793) Breast Pathology biopsy report
52
605
0.86
0.49
1.4
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
129
1174
1.10
0.49
2.5
2.7
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
101
907
1.12
0.49
1.6
1.6
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
11
76
1.45
0.48
1.5
1.2
%
90.2
109.5
0.75
11
66
(3022621) pH of Urine by Test strip
195
1812
1.08
0.47
3.2
3.2
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
22
173
1.27
0.46
1.2
1.1
nmol/l
7.5
7.5
—
5
38
(3003740) Influenza virus B Ag [Presence] in Specimen
35
291
1.21
0.46
1.6
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
35
291
1.21
0.46
1.6
1.1
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
135
1237
1.10
0.46
2.0
1.9
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
7
49
1.43
0.46
1.7
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
57
496
1.15
0.45
1.5
1.5
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
25
202
1.24
0.43
1.2
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
41
349
1.18
0.43
1.2
1.3
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
21
166
1.27
0.43
1.3
1.3
mmol/l
10.3
12.1
0.64
11
61
(3034274) Bile acid [Moles/volume] in Serum --fasting
21
166
1.27
0.43
1.6
1.8
umol/l
4.6
10.6
0.91
14
106
(3027944) Amphetamines [Presence] in Urine
53
461
1.15
0.43
1.4
1.9
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
31
371
0.83
0.42
3.0
4.9
umol/l
364.6
349.5
0.22
24
320
(3047181) Lactate [Moles/volume] in Blood
99
898
1.11
0.42
6.9
6.3
mmol/l
1.4
1.3
0.49
87
788
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
32
1.56
0.42
1.0
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
173
0.75
0.42
1.3
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
33
1.52
0.41
1.4
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
5
33
1.52
0.41
1.0
1.6
—
—
—
0
0
(3026029) Penicillin V IgE Ab [Units/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
0.2
—
0
5
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
341
3252
1.05
0.40
1.4
1.4
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
34
1.47
0.40
1.2
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
39
334
1.17
0.39
1.1
1.1
—
9.9
—
0
17
(3014051) Protein [Presence] in Urine by Test strip
74
665
1.12
0.38
2.4
2.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
68
1.32
0.37
5.3
7.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
14
107
1.31
0.37
1.1
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
8
115
0.69
0.37
1.6
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
17
213
0.80
0.36
1.1
1.0
u/ml
1.9
2.2
—
7
74
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
81
1.36
0.36
1.2
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
60
671
0.89
0.36
1.5
1.6
e6/l
12097.2
14976.3
0.35
45
473
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
71
1.27
0.36
1.0
1.4
ug/l
10.8
9.1
—
9
71
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
62
691
0.90
0.35
2.1
1.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
19
153
1.24
0.35
1.3
1.8
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
23
277
0.83
0.35
1.1
1.0
u/ml
0.6
4.3
4.18
13
125
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
6
43
1.40
0.35
1.5
1.3
%
50.4
75.2
—
6
37
(3011648) Oxygen content in Venous blood
19
232
0.82
0.33
1.1
1.8
%
12.1
11.2
0.33
19
232
(3023511) Choriogonadotropin [Units/volume] in Urine
22
182
1.21
0.33
1.1
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
62
687
0.90
0.33
1.8
1.8
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
21
173
1.22
0.32
1.6
1.5
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
107
1153
0.93
0.32
1.0
1.0
—
—
—
0
0
(4027681)
16
128
1.25
0.32
1.2
1.2
—
—
—
0
0
(3023383) Lactate [Moles/volume] in Pleural fluid
13
101
1.29
0.31
1.4
1.4
mmol/l
2.8
3.1
0.24
13
90
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
7
52
1.35
0.31
7.9
2.8
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
27
230
1.18
0.31
1.1
1.4
u/l
19.9
28.8
1.14
19
186
(3024869) Neuronal Ab [Presence] in Serum
7
53
1.32
0.30
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
159
1684
0.94
0.30
1.2
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
40
450
0.89
0.28
1.5
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
63
1.27
0.27
1.8
1.5
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
16
194
0.82
0.27
1.1
1.0
u/ml
3.7
3.4
—
7
69
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
117
0.77
0.27
1.2
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
9
119
0.76
0.27
1.1
1.5
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
8
66
1.21
0.26
1.6
1.4
—
—
—
0
0
(4211845)
11
138
0.80
0.25
2.5
4.0
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
19
160
1.19
0.25
1.6
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
74
1.22
0.25
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
75
1.20
0.25
1.3
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
76
1.18
0.24
1.3
1.1
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
12
96
1.25
0.24
1.2
2.0
ug/l
25.2
103.4
0.46
12
85
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
75
697
1.08
0.23
2.7
2.3
ug/min
247.1
101.6
0.69
43
422
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
28
246
1.14
0.23
1.9
2.1
u/field
3.2
2.1
0.44
14
90
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
23
199
1.16
0.23
1.1
1.1
—
3.9
—
0
12
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
13
106
1.23
0.23
2.7
2.5
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
66
611
1.08
0.23
4.1
3.7
mg/l
28.1
28.6
0.04
40
383
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
39
1.28
0.23
1.4
1.5
umol/l
59.0
44.4
—
5
39
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
68
631
1.08
0.22
2.5
3.3
u/ml
398.4
757.4
0.30
58
580
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
347
3573
0.97
0.22
8.5
7.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
18
153
1.18
0.22
2.2
2.1
ug/min
16.7
180.7
—
6
34
(3019150) Specific gravity of Urine by Refractometry
548
5600
0.97
0.21
4.2
4.4
kg/l
1.0
1.0
1.02
85
850
(4010399)
199
1913
1.04
0.21
1.4
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
37
409
0.90
0.21
1.1
1.1
iu/ml
63.6
97.3
—
7
84
(3007542) Rye IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
11
0.00
0.21
0.0
1.1
—
7.7
—
0
11
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
10
0.00
0.21
0.0
1.3
—
2.6
—
0
10
(3007700) Barley IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.1
—
0.2
—
0
5
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
0.4
—
0
5
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
5.6
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.4
—
1.0
—
0
8
(3020618) Glucose [Moles/volume] in Synovial fluid
0
13
0.00
0.21
0.0
1.1
—
5.1
—
0
6
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
60
646
0.93
0.20
1.6
1.4
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
28
313
0.89
0.20
1.1
1.1
u/ml
0.1
1.7
—
9
125
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
79
744
1.06
0.19
1.3
1.4
—
—
—
0
0
(4133840)
6
53
1.13
0.18
1.2
1.2
—
—
—
0
0
(4024509)
31
280
1.11
0.18
1.5
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
7
58
1.21
0.18
6.6
7.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
82
1.22
0.17
3.9
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
82
1.22
0.17
3.9
2.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
158
1.14
0.16
1.7
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
11
92
1.20
0.16
1.2
1.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
73
1.10
0.15
1.1
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
35
380
0.92
0.15
1.8
1.5
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
80
0.75
0.15
1.0
1.1
miu/ml
2113.7
1664.7
—
6
80
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
82
1.10
0.15
1.4
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
82
1.10
0.15
1.4
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
83
1.08
0.14
1.0
1.1
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
17
150
1.13
0.14
1.8
1.5
pmol/l
42.1
67.2
—
10
51
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
27
246
1.10
0.14
1.2
1.5
%
19.9
29.0
0.78
14
152
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
34
367
0.93
0.14
1.2
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
96
0.83
0.13
1.1
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
8
99
0.81
0.13
1.1
1.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
950
9410
1.01
0.12
4.5
5.1
ug/l
3.0
3.6
0.33
837
8378
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
11
127
0.87
0.12
1.2
1.4
—
1.4
—
0
8
(3009508) Creatinine [Moles/volume] in Urine
861
8691
0.99
0.11
3.1
3.2
mmol/l
7.2
7.3
0.29
713
7196
(3008401) Mugwort IgE Ab [Units/volume] in Serum
25
271
0.92
0.11
1.0
1.1
u/ml
0.1
1.3
—
9
105
(3006462) Nitrate [Presence] in Urine
11
126
0.87
0.11
2.5
4.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
14
124
1.13
0.11
1.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
161
1570
1.03
0.10
1.3
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
149
1452
1.03
0.10
1.7
1.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
44
1.14
0.10
1.4
1.5
ng/l
81.3
123.4
—
5
44
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
135
1315
1.03
0.10
1.7
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
39
369
1.06
0.09
1.9
2.2
mg/l
14.8
23.4
—
5
86
(1761868) Lipid panel - Serum or Plasma
818
8116
1.01
0.09
3.9
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
253
2572
0.98
0.09
1.6
1.6
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
63
607
1.04
0.08
1.8
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
64
0.78
0.08
3.4
2.9
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
7
65
1.08
0.08
4.1
5.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
7
67
1.04
0.08
1.0
1.1
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
6
74
0.81
0.07
1.0
1.1
u/ml
—
0.5
—
0
10
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
78
1.03
0.07
2.0
1.7
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
9
85
1.06
0.07
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
14
128
1.09
0.06
2.0
1.2
nmol/l
198.6
137.2
1.43
14
128
(44806420)
8
95
0.84
0.06
2.1
2.4
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
13
142
0.92
0.06
1.1
1.1
u/l
0.9
1.2
—
6
74
(3010726) Horse dander IgE Ab [Units/volume] in Serum
23
244
0.94
0.06
1.0
1.0
u/ml
5.1
1.8
—
5
54
(4094501)
71
729
0.97
0.06
1.1
1.1
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
11
121
0.91
0.06
1.2
1.3
umol/l
20.4
24.3
0.19
11
115
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
52
537
0.97
0.06
2.0
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
847
8427
1.01
0.05
3.2
3.2
mg/l
1575.4
307.1
3.59
527
5318
(40768441) Liver Pathology biopsy report
19
179
1.06
0.05
1.1
1.4
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
35
337
1.04
0.04
1.3
1.5
%
69.2
60.9
0.61
20
208
(3005570) Glucose [Moles/volume] in Urine
28
292
0.96
0.04
2.2
2.0
—
—
—
0
0
(1002224) Polysomnography panel
88
864
1.02
0.04
1.0
1.1
—
—
—
0
0
(4281824)
28
270
1.04
0.03
1.2
1.2
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
19
181
1.05
0.03
2.1
2.1
ug/l
2.2
2.1
0.14
19
155
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
138
0.94
0.02
1.1
1.0
—
—
—
0
0
(44813793)
16
152
1.05
0.02
1.1
1.0
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
54
550
0.98
0.02
1.3
1.8
nmol/l
0.8
0.8
0.03
45
449
(3035320) C reactive protein [Mass/volume] in Body fluid
18
187
0.96
0.01
1.9
2.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
887
8883
1.00
0.01
3.9
4.0
mg/mmol
13.9
8.8
1.55
538
5567
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
55
543
1.01
0.01
1.3
1.4
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
19
184
1.03
0.00
1.3
1.4
promille
1.2
1.2
0.03
12
142
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
26
254
1.02
0.00
1.8
1.5
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
19
185
1.03
0.00
2.1
2.0
ug/l
4.2
3.3
0.25
19
164
(3045424) Erythrocytes [Presence] in Urine
46
461
1.00
0.00
1.3
1.5
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
114
0.96
0.00
1.0
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
23
226
1.02
0.00
1.7
1.5
nmol/l
0.2
0.3
0.23
17
169
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
16
158
1.01
0.00
1.4
1.2
—
—
—
0
0
(4146454)
32
322
0.99
0.00
3.4
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
237
2366
1.00
0.00
3.5
3.5
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
26
257
1.01
0.00
1.3
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
69
0.87
0.00
1.2
1.5
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
69
0.87
0.00
1.3
1.5
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
84
0.95
0.00
1.0
1.5
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012989) Citrate [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
2.4
—
0
7
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
5
0.00
0.00
0.0
1.6
—
2984.0
—
0
5
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
4.1
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
1.6
—
0
5
(3009677) Dengue virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015147) Influenza virus A IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
8
79
1.01
0.00
3.0
2.2
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
6.8
—
67.0
—
0
6
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
211.2
—
0
5
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
1.6
—
0
5
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
59
590
1.00
0.00
1.3
1.9
iu/l
2.7
4.6
2.22
18
191
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
1.3
—
0
8
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
1478.7
—
0
6
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006567) Chloride [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
73
0.96
0.00
1.3
1.1
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
1270.0
—
0
5
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
25.8
—
0
5

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: MYELOPROF – Myeloproliferative diseases

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).